FUCHS
Clinical trials for FUCHS explained in plain language.
Never miss a new study
Get alerted when new FUCHS trials appear
Sign up with your email to follow new studies for FUCHS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye drops aim to improve fuchs dystrophy treatment before surgery
Disease control Recruiting nowThis study tests an experimental eye drop called DT-168 in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see how the drops affect disease markers and whether they are safe. About 28 adults aged 30 and older will…
Matched conditions: FUCHS
Phase: PHASE2 • Sponsor: Design Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New trial aims to find best surgery for fuchs dystrophy patients
Disease control Recruiting nowThis study compares two eye surgeries for Fuchs endothelial dystrophy, a condition that blurs vision. 60 adults will receive either a standard corneal transplant (DMEK) or a newer procedure that strips damaged cells and uses a special eye drop (Ripasudil). The goal is to see whic…
Matched conditions: FUCHS
Phase: PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC